Janux Therapeutics (JANX) IPO Doubles on Open

Today's IPO for Janux Therapeutics (NASDAQ: JANX) opened for trading at $34 after pricing 11,400,000 shares of its common stock at $17.

BofA Securities, Cowen and Evercore ISI are acting as joint book-running managers for the offering. H.C. Wainwright & Co. is acting as lead manager for the offering.

Janux Therapeutics is a biopharmaceutical company developing novel T cell engager immunotherapies.

You May Also Be Interested In

• Trump: Iran cannot have, in any way, shape, or form, a nuclear weapon
• Sinda raises $331M in IPO, reports Q2 net loss of $16.6M
• Bang Mai Fang files for 5M share IPO at $5-$6/sh